SCHEMBL7216211

SCHEMBL7216211

c1ccc(CNc2ncnc3c2[nH]c2ccccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 1.00
KDM4E B2RXH2 9/20 0.76
MAPK1 P28482 5/20 0.76
MAPT P10636 3/20 0.76
OXTR P30559 1/20 0.76
MEN1 O00255 2/20 0.73
KMT2A Q03164 2/20 0.73
GAA P10253 2/20 0.73
ALDH1A1 P00352 7/20 0.66
LMNA P02545 7/20 0.66
HTT P42858 7/20 0.66
HSD17B10 Q99714 4/20 0.66
SMN1; SMN2 Q16637 5/20 0.58
TSHR P16473 3/20 0.58
HPGD P15428 1/20 0.58
TP53 P04637 1/20 0.57
GALR3 O60755 3/20 0.55
RAB9A P51151 2/20 0.55
NR2F2 P24468 2/20 0.55
UTS2R Q9UKP6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15452471 0.90 EGFR (0.81) EGFRKDM4EMAPK1MAPTOXTR
SCHEMBL23682881 0.85 KMT2A (1.00) EGFRKDM4EMAPK1MAPTOXTR
SCHEMBL15452736 0.83 MAPK1 (0.75) EGFRKDM4EMAPK1MAPTOXTR
SCHEMBL10083177 0.79 EGFR (0.65) EGFRKDM4EMAPK1MAPTOXTR
SCHEMBL7215763 0.78 EGFR (0.97) EGFRKDM4EMAPK1MAPTOXTR
Hydrochloric Acid SCHEMBL7215860 0.77 EGFR (1.00) EGFRKDM4EMAPK1MAPTOXTR
SCHEMBL168409 0.77 EGFR (0.68) EGFRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL4008118 0.73 EGFR (0.57) EGFRKDM4EMAPK1MAPTOXTR
SCHEMBL14780086 0.72 CSF1R (0.70) EGFRMAPK1MEN1KMT2AGAA
SCHEMBL15612915 0.72 LMNA (0.57) EGFRMAPK1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006055-A1 SMALL MOLECULE BROAD-SPECTRUM ANTIBIOTICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-01-04 WO disclosed
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 US disclosed
EP-0741711-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1996-11-13 EP disclosed
WO-1995019970-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1995-07-27 WO disclosed